Southeast Asia's Pioneer of Integrated Solutions in
Regenerative Medicine Cellular Biotechnology and Longevity Health Technology
Committed to the selection and integration of beauty and health. Headquartered in Singapore, a leading integrated healthcare service provider in Southeast Asia.
Our Products
Medical Aesthetics
Advanced aesthetic solutions including PDRN-based treatments for professional clinic use across Southeast Asia.
Advanced Nutritional Science
Formulated with high-purity bioactive ingredients to optimize cellular function and support long-term vitality.
Advanced Cellular Aesthetics
Cutting-edge cellular beauty solutions harnessing bioactive technology for advanced skin rejuvenation and longevity.
Our Capabilities
Wholesale & Distribution
Reliable wholesale supply and regional distribution services, connecting premium healthcare brands with clinics and distributors across Southeast Asia.
Compliance Experts & Health Products
Compliance experts ensure health products are fully regulatory-compliant.
Supply Chain Assurance
We maintain a stable, high-quality supply chain with robust logistics and quality control, ensuring consistent product availability.
Celluvion International Group
Headquartered in Singapore, a leading integrated healthcare service provider in Southeast Asia.
Bridging Medical Aesthetics, Holistic Health Innovation across the region.
Built for Compliance,
Scale & Reliability
Through strong regional networks and local expertise, we help partners enter the market efficiently, operate compliantly, and maintain a stable, high-quality supply chain.
Wholesale & Distribution
Reliable wholesale supply and regional distribution services, connecting premium healthcare brands with clinics and distributors across Southeast Asia.
Compliance Experts & Health Products
Compliance experts ensure health products are fully regulatory-compliant.
Supply Chain Assurance
We maintain a stable, high-quality supply chain with robust logistics and quality control, ensuring consistent product availability.
Partner With
Celluvion
Clinic Partnerships
We partner with aesthetic clinics and medical practices across Southeast Asia, providing access to premium products, training support, and marketing materials.
International Distribution
Expand your reach across Southeast Asia with our established distribution network spanning Singapore, Malaysia, Thailand, Vietnam, and beyond.
Celluvion
International Group
Leading Healthcare in Southeast Asia
Headquartered in Singapore, Celluvion International Group is a leading integrated healthcare service provider in Southeast Asia.
We deliver end-to-end solutions; from product introduction, cross-nation trade to terminal promotion, bridging Medical Aesthetics and Holistic Health Innovation across the region.
Advancing Healthcare
Across Southeast Asia
Our mission is to bridge the gap between cutting-edge global biomedical innovation and clinical practice across Southeast Asia. We are committed to delivering premium regenerative medicine, cellular biotechnology, and longevity health solutions that empower healthcare professionals to provide the highest standard of patient care — with integrity, compliance, and scientific rigour at every step.
To Be the Region's Most Trusted
Integrated Health Partner
We envision a Southeast Asia where every clinic, practitioner, and patient has access to world-class regenerative and longevity health technologies. By building a robust, compliant, and innovation-driven distribution ecosystem, Celluvion aims to become the region's most trusted integrated health partner — connecting science, commerce, and compassionate care.
Industry
Intelligence
Joining Forces to Venture Overseas and Usher in the “Collagen Era”: Celluvion International and Chumsun Biological Officially Sign Strategic Cooperation Agreement
Celluvion International Group · Singapore · April 2026
Recently, Celluvion International, led by Chairman Leng Wenlong, and Zhejiang Chumsun Biological Products Co., Ltd. held a grand strategic cooperation signing ceremony. This agreement marks the formal establishment of both parties as steadfast core partners, jointly committed to exploring the expansive medical device and medical aesthetics markets in Southeast Asia, and advancing premium Chinese collagen products onto the global stage.
Strong Alliance to Seize the Overseas Expansion Opportunity
At the signing ceremony, Chairman Zhang Zhiwu (Dr Zhang) of Chumsun Biological expressed high expectations and firm support for the collaboration. Dr Zhang stated, “Chumsun Biological's products demonstrate robust quality and efficacy, particularly exhibiting outstanding durability in animal studies, which has thoroughly challenged the perceptions of overseas experts.”
Chairman Leng Wenlong (left) and Chairman Zhang Zhiwu (Dr Zhang) at the 2026 Strategic Cooperation Signing Ceremony.
By aligning with the regulatory frameworks and market access characteristics of various overseas markets, Chumsun Biological will fully cooperate with and support Celluvion International, leveraging Celluvion’s professional expertise and overseas experience to jointly realise their overseas expansion objectives.
Chairman Leng conveyed sincere gratitude for Chumsun Biological's trust. After years of in-depth market research, the team identified that the Southeast Asian market remains predominantly reliant on hyaluronic acid (HA), with domestic medical device products having minimal presence locally. Notably, there exists a significant market gap for bovine Achilles tendon collagen products. This current landscape presents an excellent opportunity for collaboration between both parties.
Core Advantage: Transitioning from the “Hyaluronic Acid Era” to the “Collagen Era”
Currently, the Southeast Asian medical aesthetics market commonly faces issues such as facial “puffiness” and sagging caused by prolonged HA injections. Celluvion International highlighted that magnetic resonance imaging has revealed that in some patients, injected HA remains unabsorbed for years and continues to absorb water and expand. In contrast, collagen products offer marked advantages in terms of safety, natural appearance, and growth potential.
For this overseas venture, Celluvion International will centre on Chumsun Biological's high-quality collagen products, dedicating efforts to comprehensive market education and brand promotion in Southeast Asia. Through expert conferences and academic exchanges, they aim to gradually shift local consumer perceptions and lead the Southeast Asian medical aesthetics market from the “Hyaluronic Acid Era” into a safer, more natural “Collagen Era”.
Robust Pipeline Outlining a Global Vision
This strategic cooperation not only focuses on foundational collagen products but also looks ahead to sustained innovation. Celluvion International revealed that both parties will develop a diversified product pipeline centred on collagen, including specialised products targeting periocular indications and combination products incorporating other materials. By continuously launching new licences and products annually, they will enrich their overseas product portfolio.
Regarding future development plans, Chairman Leng expressed strong confidence. He stated that this overseas expansion is not only the “first” for Celluvion International and Chumsun Biological but also a milestone worthy of being recorded in the history of both companies’ growth. Moving forward, they will establish a presence in key cities and countries across Southeast Asia, gradually increasing market share and brand reputation, while seizing opportunities to enter broader international markets such as Europe and the United States.
The joint teams of Celluvion International and Chumsun Biological at the 2026 Strategic Cooperation Signing Ceremony.
Conclusion
“Do not aim too high too soon; focus on doing the present tasks well, step by step.”
This pragmatic commitment embodies Celluvion International’s ethos and represents the shared vision of both parties. Marking the signing as a new beginning, Celluvion International and Chumsun Biological will advance side by side, navigating the vast overseas markets and jointly writing a new chapter for Chinese medical aesthetics brands going global.
Partner With
Celluvion
Let's Start a Conversation
Whether you're interested in clinic partnerships, distribution opportunities, or have product enquiries, our team is ready to assist you.
Send an Enquiry
Our Products
Celluvion offers a comprehensive range of premium healthcare products across three core categories, each backed by clinical research and regulatory compliance.
Custom Cosmetics
Advanced aesthetic solutions including PDRN-based treatments for professional clinic use across Southeast Asia. Our portfolio covers skin rejuvenation, anti-aging therapies, and non-invasive aesthetic procedures designed for clinical excellence.
Aesthetic Injectables
Premium injectable solutions for facial rejuvenation, contouring and skin bio-regulation. Our curated portfolio includes Halal-certified collagen implants, hyaluronic acid fillers, skin bio-regulators and PCL-based collagen stimulators.
Medical Skincare
Post-Treatment Care
Integrated Solutions
Structured solution sets designed to support clinical procedures and extend treatment results.
Medical Aesthetic Injectables
Premium injectable solutions for facial rejuvenation, contouring and skin bio-regulation, curated for professional clinic use across Southeast Asia.
Halal Collagen
JIAO YUAN TIANSHI · Medical Collagen Implant
The world's first high-activity, high-purity natural collagen implant derived from bovine Achilles tendon. Fully natural composition with no chemical cross-linking agents. Concentration 45mg/ml — 28.75% higher than the mainstream 35mg/ml on the market. Approved as a Class III Medical Device in China.
Leading integrated healthcare service provider in Southeast Asia.